News
HSCSW
0.0401
-8.86%
-0.0039
BUZZ-U.S. STOCKS ON THE MOVE-Tilray Brands, Arbutus Biopharma, Coinbase
Wall Street's main indexes were little changed on Friday. Investors took a breather from the week's rally driven by growing expectations of interest-rate cuts this year. Tilray Brands, Arbutus Biopharma, and Coinbase Global were among the stocks on the move.
Reuters · 18h ago
Weekly Report: what happened at HSCSW last week (0506-0510)?
Weekly Report · 5d ago
HEART TEST LABORATORIES: ON MAY 9, RECEIVED STAFF DETERMINATION FROM NASDAQ TO DELIST CO'S SECURITIES FROM NASDAQ CAPITAL MARKET
Reuters · 05/10 20:20
Weekly Report: what happened at HSCSW last week (0429-0503)?
Weekly Report · 05/06 10:02
Weekly Report: what happened at HSCSW last week (0422-0426)?
Weekly Report · 04/29 10:04
HEARTSCIENCES ANNOUNCES GRANT OF FUNDAMENTAL PATENT BY THE EUROPEAN PATENT OFFICE COVERING ASSESSMENT OF DIASTOLIC FUNCTION OF THE HEART USING AI-ECG
Reuters · 04/24 13:02
Weekly Report: what happened at HSCSW last week (0415-0419)?
Weekly Report · 04/22 10:00
Weekly Report: what happened at HSCSW last week (0408-0412)?
Weekly Report · 04/15 09:56
Weekly Report: what happened at HSCSW last week (0401-0405)?
Weekly Report · 04/08 09:58
HeartSciences to Present at the LD Micro Invitational XIV Conference
Chief Executive Officer Andrew Simpson is scheduled to present at the LD Micro Invitational XIV Conference on April 9, 2024. Heart Test Laboratories, Inc. Is a medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The conference will be held in New York.
Barchart · 04/02 15:15
Weekly Report: what happened at HSCSW last week (0325-0329)?
Weekly Report · 04/01 09:58
Weekly Report: what happened at HSCSW last week (0318-0322)?
Weekly Report · 03/25 09:59
Weekly Report: what happened at HSCSW last week (0311-0315)?
Weekly Report · 03/18 09:58
Heart Test Laboratories Inc: Quarterly report
Press release · 03/14 20:42
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
Heart Test Laboratories, Inc. Reports financial results for the third quarter fiscal 2024 ended January 31, 2024. The company is an artificial intelligence-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Heart Test Laboratories reports a business update.
Barchart · 03/14 15:15
Weekly Report: what happened at HSCSW last week (0304-0308)?
Weekly Report · 03/11 09:57
BUZZ-U.S. STOCKS ON THE MOVE-CrowdStrike, SoFi Technologies, JD.com
U.S. Stock index futures rise on Wednesday as investors await testimony by Jerome Powell before Congress. Dow e-minis were up 0.24% at 38,698.5. JD.com up 11.2% in premarket trading. CrowdStrike, SoFi Technologies, Ross Stores among the top stocks on the move.
Reuters · 03/06 12:17
Weekly Report: what happened at HSCSW last week (0226-0301)?
Weekly Report · 03/04 09:58
Weekly Report: what happened at HSCSW last week (0219-0223)?
Weekly Report · 02/26 10:04
Weekly Report: what happened at HSCSW last week (0212-0216)?
Weekly Report · 02/19 10:05
More
Webull provides a variety of real-time HSCSW stock news. You can receive the latest news about Heart Test Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About HSCSW
Heart Test Laboratories, Inc., doing business as HeartSciences, is an artificial intelligence electrocardiogram (AI ECG) company. The Company is focused on using AI to transform ECG to save lives through earlier detection of heart disease. The Company’s initial focus is on applying technology to extend the clinical indications for use of an electrocardiograph (ECG) device. Its first device, the MyoVista is an ECG that can be used in a range of clinical settings and provides diagnostic information to a qualified healthcare professional on cardiac dysfunction which has traditionally only been provided using cardiac imaging. In addition, MyoVista provides conventional ECG information. The Company focuses on marketing its device both domestically and internationally to various hospitals, clinics, and medical centers and manufacturing the devices using outsourced production facilities.